Multikinase inhibitors

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

Filter by:
Drug Name DownUp( View by: Brand | Generic ) Reviews Ratings DownUp
dabrafenib systemic (Pro, More...)
1 review
   
Rate it
9.0
trametinib systemic (Pro, More...)
1 review
   
Rate it
9.0
vemurafenib systemic (Pro, More...)
2 reviews
   
Rate it
9.0
crizotinib systemic (Pro, More...)
1 review
   
Rate it
8.0
sunitinib systemic (Pro, More...)
13 reviews
   
Rate it
7.5
sorafenib systemic (Pro, More...)
6 reviews
   
Rate it
7.4
ibrutinib systemic (More...)
1 review
   
Rate it
7.0
axitinib systemic (Pro, More...)
0 reviews
   
Rate it
6.0
ruxolitinib systemic (Pro, More...)
0 reviews
   
Rate it
1.0
afatinib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
cabozantinib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
ceritinib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
idelalisib systemic (More...)
0 reviews
   
Rate it
0.0
nintedanib systemic (More...)
0 reviews
   
Rate it
0.0
ponatinib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
regorafenib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
vandetanib systemic (Pro, More...)
0 reviews
   
Rate it
0.0
Hide
(web3)